» Articles » PMID: 33837797

Microablative Radiofrequency Versus Pelvic Floor Muscle Training for Stress Urinary Incontinence: a Randomized Controlled Trial

Overview
Publisher Springer
Date 2021 Apr 10
PMID 33837797
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction And Hypothesis: The efficacy of radiofrequency (RF) in stress urinary incontinence (SUI) is as yet unknown. The aim was to compare the effect of fractional microablative RF and pelvic floor muscle training (PFMT) against the combination of both therapies (RF + PFMT) in the SUI and on genitourinary syndrome (GSM).

Methods: This was a three-arm randomized clinical trial including 117 climacteric women with SUI. In group 1 the treatment consisted of three monthly sessions of RF; in group 2 it was 12 weekly PFMT sessions; in group 3 it was RF + PFMT simultaneously. Assessments at baseline and 30 days after the end of therapy were conducted using validated questionnaires and scales for urinary, vaginal, and sexual functions and cytology for vaginal trophy.

Results: Urinary scores improved significantly in all three groups post-treatment (p < 0.001) with a higher improvement in the RF + PFMT group (p = 0.002). One-hour pad test results were equal in the three groups. Vaginal symptoms showed an incremental improvement in RF (p < 0.007), and vaginal laxity showed a similar improvement in the three groups (p = 0.323). Vaginal Health Index score was more significant in RF and RF + PFMT groups. Sexual function improved in RF and PFMT.

Conclusions: The association between RF and PFMT showed significant improvement in the SUI symptoms assessed by questionnaire. The vaginal symptoms and dryness showed greater improvement in the RF treatment and vaginal laxity showed similar improvement in the three groups. The combination of RF and PFMT in sexual function did not show benefits superior to those achieved by the therapies alone.

Citing Articles

How Long Does Urinary Continence Last After Treatment with Intravaginal CO Laser and Microablative Radiofrequency? A Four-Year Follow-up of a Multi-arm Randomized Clinical Trial (LARF-arm3).

Seki A, de Mello Bianchi-Ferraro A, Bonetti T, Fonseca E, Sartori M, de Jarmy-Di Bella Z Int Urogynecol J. 2025; .

PMID: 39945802 DOI: 10.1007/s00192-025-06076-3.


Conservative treatments for women with stress urinary incontinence: a systematic review and network meta-analysis.

Li M, Qiu K, Guo H, Fan M, Yan L Front Med (Lausanne). 2024; 11:1517962.

PMID: 39703522 PMC: 11656316. DOI: 10.3389/fmed.2024.1517962.


Applicability of vaginal energy-based devices in urogynecology: evidence and controversy.

Machado A, Judice L, Riccetto C, Toledo L Rev Assoc Med Bras (1992). 2023; 69(suppl 1):e2023S129.

PMID: 37556648 PMC: 10411715. DOI: 10.1590/1806-9282.2023S129.


Sexual function after energy-based treatments of women with urinary incontinence. A systematic review and meta-analysis.

Pavarini N, Valadares A, Varella G, Brito L, Juliato C, Costa-Paiva L Int Urogynecol J. 2023; 34(6):1139-1152.

PMID: 36680596 DOI: 10.1007/s00192-022-05419-8.


Effect of vaginal energy-based treatment on female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials.

Zhang C, Chen Y, Liu S, Chen J, Shen H, Luo D World J Urol. 2022; 41(2):405-411.

PMID: 36536169 DOI: 10.1007/s00345-022-04247-1.

References
1.
Dumoulin C, Cacciari L, Hay-Smith E . Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018; 10:CD005654. PMC: 6516955. DOI: 10.1002/14651858.CD005654.pub4. View

2.
Vicariotto F, Raichi M . Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Minerva Ginecol. 2016; 68(3):225-36. View

3.
Caruth J . Evaluation of the Safety and Efficacy of a Novel Radiofrequency Device for Vaginal Treatment. Surg Technol Int. 2018; 32:145-149. View

4.
Leibaschoff G, Izasa P, Cardona J, Miklos J, Moore R . Transcutaneous Temperature Controlled Radiofrequency (TTCRF) for the Treatment of Menopausal Vaginal/Genitourinary Symptoms. Surg Technol Int. 2016; 29:149-159. View